Details for New Drug Application (NDA): 011870
NDA 011870 describes DIURIL, which is a drug marketed by Rising and Salix Pharms and is included in two NDAs. It is available from one supplier. Additional details are available on the DIURIL profile page.
The generic ingredient in DIURIL is chlorothiazide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorothiazide profile page.
The generic ingredient in DIURIL is chlorothiazide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorothiazide profile page.
Summary for 011870
| Tradename: | DIURIL |
| Applicant: | Salix Pharms |
| Ingredient: | chlorothiazide |
| Patents: | 0 |
Pharmacology for NDA: 011870
| Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for 011870
Suppliers and Packaging for NDA: 011870
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DIURIL | chlorothiazide | SUSPENSION;ORAL | 011870 | NDA | Salix Pharmaceuticals, Inc | 65649-311 | 65649-311-12 | 1 BOTTLE in 1 CARTON (65649-311-12) / 237 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 250MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
